Dexcom Inc [NASDAQ: DXCM] loss -0.04% or -0.03 points to close at $84.1 with a heavy trading volume of 4777054 shares.
It opened the trading session at $84.09, the shares rose to $85.9 and dropped to $83.54, the range by which the price of stock traded the whole day. The daily chart for DXCM points out that the company has recorded 6.23% gains over the past six months.
If we look at the average trading volume of 3.61M shares, DXCM reached to a volume of 4777054 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Dexcom Inc [DXCM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DXCM shares is $100.84 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DXCM stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for Dexcom Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 16, 2025. While these analysts kept the previous recommendation, Goldman raised their target price to Buy. The new note on the price target was released on May 30, 2025, representing the official price target for Dexcom Inc stock. Previously, the target price had yet another raise to $85, while Mizuho analysts kept a Outperform rating on DXCM stock. On February 03, 2025, analysts increased their price target for DXCM shares from 85 to 115.
The Price to Book ratio for the last quarter was 14.55, with the Price to Cash per share for the same quarter was set at 6.89. Price to Free Cash Flow for DXCM in the course of the last twelve months was 57.33 with Quick ratio for the last quarter at 1.32.
Trading performance analysis for DXCM stock
Dexcom Inc [DXCM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.59. With this latest performance, DXCM shares gained by 1.33% in over the last four-week period, additionally plugging by 6.23% over the last 6 months – not to mention a rise of 8.14% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DXCM stock in for the last two-week period is set at 50.47, with the RSI for the last a single of trading hit 2.24, and the three-weeks RSI is set at 2.38 for Dexcom Inc [DXCM]. The present Moving Average for the last 50 days of trading for this stock 84.55, while it was recorded at 84.34 for the last single week of trading, and 78.19 for the last 200 days.
Dexcom Inc [DXCM]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Dexcom Inc [DXCM] shares currently have an operating margin of 15.25% and a Gross Margin at 59.43%. Dexcom Inc’s Net Margin is presently recorded at 12.90%.
Dexcom Inc (DXCM) Capital Structure & Debt Analysis
According to recent financial data for Dexcom Inc. ( DXCM), the Return on Equity (ROE) stands at 23.72%, reflecting robust shareholder value creation. The Return on Assets (ROA) is 8.09%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Dexcom Inc’s Return on Invested Capital (ROIC) is 14.78%, showcasing its effectiveness in deploying capital for earnings.
Dexcom Inc (DXCM) Efficiency & Liquidity Metrics
Based on Dexcom Inc’s (DXCM) latest financial statements, the Debt-to-Equity Ratio is 1.14%, indicating its reliance on debt financing relative to shareholder equity.
Dexcom Inc (DXCM) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Dexcom Inc. (DXCM) effectively leverages its workforce, generating an average of $51961.17 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.50% and a Quick Ratio of 1.32%, indicating strong ability to cover short-term liabilities.
Dexcom Inc [DXCM]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DXCM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Dexcom Inc go to 24.04%.
An analysis of Institutional ownership at Dexcom Inc [DXCM]
There are presently around $97.10%, or 97.51% of DXCM stock, in the hands of institutional investors. The top three institutional holders of DXCM stocks are: VANGUARD GROUP INC with ownership of 46.51 million shares, which is approximately 11.6516%. BLACKROCK INC., holding 34.52 million shares of the stock with an approximate value of $$3.91 billion in DXCM stocks shares; and BLACKROCK INC., currently with $$1.85 billion in DXCM stock with ownership which is approximately 4.0853%.
